Gloshell
成分词典

成分词典

DODECENE

1-dodecene is an alkene that is dodecane containing one double bond at position 1.

分子结构

定义

1-dodecene is an alkene that is dodecane containing one double bond at position 1. It is an intermediate used in the production of lubricants and surfactants. It has a role as a mammalian metabolite and a human metabolite. It is a volatile organic compound and a dodecene.

来源: PubChem

美国FDA 物质登记 · UNII WYE669F3GR · 登记名称 1-Dodecene · 单一化学物质

来源: 美国FDA 物质识别码(UNII)

化妆品中的作用

溶解其他成分的基质SOLVENT调节黏度VISCOSITY CONTROLLING登记为香料组成物质(并非表示其增香)FRAGRANCE

安全与法规参考

未列入韩国有毒物质 GHS 分类 · 现有化学物质

来源: 韩国有毒物质 GHS 信息(环境公团)

详细资料——标示名称、识别编号、物性、试验记录、文献

官方标示名称和定义

日本化妆品工业联合会标示名称 ドデセン: 本品は、次の化学式で表される不飽和炭化水素である。

来源: 日本化妆品工业联合会标示名称

别名和识别信息

DODECENEINCI도데센韩国标示名称(食药处标准名)1-Dodecene同义名ドデセン日本标示名称
CAS No.化学物质登记号
112-41-4
EC No.欧盟化学品目录编号
203-968-4
DTXSID美国EPA化学品编号
DTXSID5026914
DTXCID美国EPA化合物编号
DTXCID306914
IUPAC
Dodec-1-ene
分子式
C12H24
分子量
168.324 g/mol

实测物性

性状
1-dodecene appears as a clear colorless liquid with a mild, pleasnat odor. Insoluble in water and floats on water. Harmful or fatal by ingestion. Inhalation of vapors may irritate and damage lungs. High concentrations may have a narcotic effect. · Liquid, CBI
气味
MILD, PLEASANT
沸点
415 °F at 760 mmHg (USCG, 1999) · 213.8 °C
熔点
-31 °F (USCG, 1999) · -35.2 °C
溶解性
Insoluble in water, sol in ethanol, ethyl ether, and acetone · Solubility in water: none
密度
0.758 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.7584 g/cu cm @ 20 °C
黏度
1.72 sq mm/s @ 20 °C · 1.72 ㎟/s
颜色
无色
熔点/凝固点
-36~-31 ℃
初沸点和沸程
208~216 ℃
闪点
77 ℃((c.c.))
燃烧或爆炸范围上限/下限
0.62 / 5.42 %
蒸气压
0.159 ㎜Hg ( (25 ℃))
蒸气密度
5.8-5.81
比重
0.7584-0.76
正辛醇/水分配系数(Kow)
6.10
自燃温度
225 ℃
分子量
168.31

这是对物质本身测得的数值。韩国安全保健公团(KOSHA)的资料仅供编写和审核安全数据表参考,并非原料商品的规格。

来源: PubChem · 韩国安全保健公团 安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 23 款产品的用途。其中包括化妆品以外的产品,排在前几行的即为该成分的主要用途。

  • Lubricating agent3
  • Viscosity modifier3
  • Deodorizer2
  • Processing aids not otherwise specified2
  • Chemical reaction regulator2
  • Intermediate2
  • Monomers1
  • Diluent1
其余用途 7 项
  • Solvent1
  • Degradant/impurity (EPA)1
  • Surfactant (surface active agent)1
  • Fuel1
  • Elasticizer1
  • Defoamer1
  • Flavouring and nutrient1

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 18 项、眼部试验 7 项。

归类为刺激性高5 项归类为中等3 项归类为低30 项

各项试验结论不一(最多的结论占 13%),因此不能断定该成分有刺激性。 这是对原料本身的试验记录,与成品中所含浓度下的刺激性不同。

查看全部 25 项试验
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Category 2
    Skin Irritation · Screening
  • Classification not possible
    Skin Sensitization · Screening
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Category 6.3A (Category 2)
    Skin Irritation · Read Across
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Not classified
    Eye Irritation · Screening

来源: 美国EPA CompTox

相关文献

关联数据库 20